• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

8 Questions on T2 Diabetes Risk Assessment Using Prediabetes Subphenotypes

Slideshow

Assessment of prediabetes subphenotypes is a novel approach to better screening, prevention, and treatment for patients at risk of progression to T2D. Find out how much you know about it.

In a recent study, researchers investigated a novel approach to assessing the risk of progression to type 2 diabetes mellitus (T2D) and complications in heterogeneous groups of patients with prediabetes. They identified 6 specific subphenotypes represented by clusters of characteristics.

Take this quick quiz to test your knowledge of key aspects of their findings.


Prediabetes subphenotype clusters: Cluster 1 Persons at low risk Cluster 2 Slim persons at very low risk Cluster 3 Persons with β-cell failure and genetic risk factors at high risk Cluster 4 Obese persons at low risk Cluster 5 Persons with insulin resistance and fatty liver at high risk Cluster 6 Persons with high levels of visceral fat, especially in the kidneys, at high risk


Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
© 2024 MJH Life Sciences

All rights reserved.